Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Neurobiol Aging. 2020 Apr 18;92:114–134. doi: 10.1016/j.neurobiolaging.2020.04.009

Fig. 11.

Fig. 11.

Effect of VSL#3 supplementation on brain concentrations of eicosanoids in C57BL/6 (WT) and AppNL-G-F mice. (a) PGD, (b) PGE2, (c) 6-keto PGF, (d) PGF, (e) thromboxane, (f) Arachidonic acid, and (g) Docosahexaenoic acid were measured using mass spectrometry in temporal cortices after 8 weeks of treatment. Data are represented as mean ± S.E.M. Significant differences were determined by two-way ANOVA, * p<0.05 (n=7 for AppNL-G-F mice and n=8 for WT mice).